Aster DM Healthcare Limited (ASTERDM) — Financial Results Announcement

· NSE 🔴 High Importance Neutral
Revenue: ₹9,273 CrNet Profit: ₹451 Cr
📢 Key Event
Aster DM Healthcare announces expansion plans and financial metrics in investor call
💡 Investor Takeaway
Shareholders should note expansion plans and margin differences may affect future profitability

Aster DM Healthcare announced expansion across multiple locations including Raipur, Bhubaneswar, Banjara, Hyderabad, Nagercoil, Nampally, Malakpet, Chattogram, and Vizag, with bed capacity additions and capability enhancements. Capex per bed ranges from INR 0.8-1.1 crores for brownfield sites and INR 1.5-1.6 crores for greenfield projects. The company highlighted minority share percentages of 8-9% for Aster, 15-20% for QCIL, and a blended 10-15%. ROCE calculations exclude revaluation reserves and CWIP, while reported EBITDA margins of 20-21% differ from annual report figures of 17-18% due to one-time merger costs.

📄 View Original Announcement (PDF)

About Aster DM Healthcare Limited (ASTERDM)

Healthcare · Healthcare Services · Listed on NSE

Market Cap: ₹39,048.19 Cr P/E: 7.1

View full ASTERDM stock details →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.